ORLANDO, Fla.--(BUSINESS WIRE)--Nano Discovery Inc. announced today that it has launched a new blood test to the market for cattle immune health testing. Cattle owners and veterinary practitioners can order this test by submitting blood samples to Nano Discovery’s central laboratory, or conduct this test in their local farms and clinics by purchasing testing kits from the company. More information can be found at: www.nanodiscoveryinc.com
A balanced immune system is important for the welfare and productivity of farm animals. Animals with good immune health are less prone to diseases, healthier and more productive. When an animal is infected with bacteria, viruses or other pathogens, the immune system of the animal is activated. An active immune status is a sign of infection in the animal. During pregnancy, the immune system of cows and heifers has to make certain changes to maintain a pregnancy to full term. However, these changes also make pregnant and transition cows and heifers more vulnerable to infectious diseases. By closely monitoring the immune status of cattle herd, farm owners can discover sick animals earlier, identify pregnant animals with underlying reproductive health problems for treatment, identify animals with strong immune system and avoid excessive use of antibiotics on healthy and low risk animals.
Despite the critical importance of immune health to the welfare and productivity of agricultural animals including cattle, there was no convenient and cost-effective test in the market that provided farm owners and veterinary practitioners the ability to test and monitor the immune health and status of their cattle easily. Nano Discovery’s new product, the D2Dx™ immunity test, provides the first-ever solution to this unmet need. D2Dx™ immunity test is a simple blood test that detects active immune responses and Th1/Th2 immunity shift associated with infection, pregnancy, and other health conditions that involve the immune system. Research studies conducted by Nano Discovery and its partners have shown that D2Dx™ test can identify cattle with infections; identify dairy cows that are more likely to develop health problems such as ketosis and mastitis following calving; and identify calves with good immune health that can gain more body weight in a feedlot. While D2Dx™ test is not a diagnostic test, the test brings many benefits to cattle owners by helping owners monitor the health of their cattle herd more closely, make informative management decisions, reduce cost and improve productivity.
“The cattle industry is huge in the United States," said Dr. Qun Treen Huo, President and CEO of Nano Discovery Inc., “but infectious diseases pose a big threat to the sustainability of this industry. Although everyone knows how important a good immune health is to the defense of infectious diseases and the overall health and productivity of the animals, there was not a simple test in the market that could allow farm owners to test the immune health of their animals easily. We are very excited and happy that we can offer our test as a new solution to help the industry."
While the current business focus of Nano Discovery is on cattle industry, D2Dx™ immunity test can be applied to the testing of other animals as well. The company is also investigating the use of this test for human infectious diseases, pregnancy loss, autoimmune diseases, and other immune health related problems. D2Dx™ test is based on a nanotechnology platform developed at the University of Central Florida, Orlando, Florida. A PCT patent application is pending on the platform technology and the D2Dx™ immunity test.
About Nano Discovery Inc.: Nano Discovery Inc. is a biotechnology company based in Orlando, Florida, United States. We develop, manufacture and sell bioassay products and diagnostic tests for infectious disease control and health management. We seek to improve the life and health of humans and animals by developing and deploying innovative technologies and products to combat the ever evolving threat of infectious pathogens. Nano Discovery’s products provide cost-effective critical information to develop targeted solutions for the prevention, management, and control of infectious diseases, reducing the use of antibiotics in humans and food animals.